CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending2018-12-312017-12-312016-12-31
Net Income-27,115-9,157-6,019
Operating Activities, Cash Flows Provided By or Used In
Depreciation47112892
Adjustments To Net Income1,887271270
Changes In Accounts Receivables---
Changes In Liabilities7,36147300
Changes In Inventories---
Changes In Other Operating Activities-2,063-768-111
Total Cash Flow From Operating Activities-19,459-9,479-5,468
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-1,059-304-190
Investments-118,399-118,399-118,399
Other Cash flows from Investing Activities---
Total Cash Flows From Investing Activities-119,458-304-190
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid---
Sale Purchase of Stock---
Net Borrowings--212-48
Other Cash Flows from Financing Activities-11,054-11,054-5
Total Cash Flows From Financing Activities170,19811,823-53
Effect Of Exchange Rate Changes---
Change In Cash and Cash Equivalents31,2812,040-5,711